Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06989658
What this trial is testing

Feasibility and Tolerability Study of Smart Contact Lens With Healthy Subjects and Patients With Stargardt's Disease

Who this might be right for
Stargardt Disease
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 32
Not applicableStudy completedNCT04390126
What this trial is testing

COVID-19 Related Lockdown Effects On Chronic Diseases

Who this might be right for
Chronic Coronary SyndromeHeart FailureAMD and Macular Edema+5 more
Centre Hospitalier Universitaire Dijon 1,343
Large-scale testing (Phase 3)Ended earlyNCT03710564
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 535
Early research (Phase 1)Active Not RecruitingNCT01736059
What this trial is testing

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Who this might be right for
Non-exudative Age-related Macular DegenerationDiabetic RetinopathyRetina Vein Occlusion+2 more
University of California, Davis 15
Not applicableUnknownNCT03517241
What this trial is testing

Objective Assessment of Macular Function at Retinal and Cortical Levels

Who this might be right for
Macula; Degeneration, Congenital or HereditaryRetina Disorder
Medical University of Vienna 100
Post-approval studies (Phase 4)Study completedNCT02689518
What this trial is testing

EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection

Who this might be right for
Macular DegenerationWet Macular Degeneration
University of California, San Diego 50
Testing effectiveness (Phase 2)Looking for participantsNCT07161544
What this trial is testing

AAVB-039 in Participants With Stargardt Disease (STGD1)

Who this might be right for
Stargardt Disease
AAVantgarde Bio Srl 75
Not applicableStudy completedNCT04084587
What this trial is testing

Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Macular Degeneration AdvancedMacular Degeneration, SenileMacular Degeneration, Dry+2 more
University of Modena and Reggio Emilia 24
Testing effectiveness (Phase 2)UnknownNCT01278277
What this trial is testing

Saffron Supplementation in Stargardt's Disease

Who this might be right for
Retinal DegenerationGenetic DiseaseSingle-Gene Defects+1 more
Catholic University of the Sacred Heart 30
Not applicableLooking for participantsNCT05976139
What this trial is testing

Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies

Who this might be right for
Macular EdemaInherited Retinal DystrophyLaser Retinopathy
Fondazione G.B. Bietti, IRCCS 10
Early research (Phase 1)Study completedNCT02543229
What this trial is testing

Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD

Who this might be right for
Eye DiseasesMacular DegenerationRetinal Diseases+2 more
Opthea Limited 51
Early research (Phase 1)Study completedNCT01003691
What this trial is testing

Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy

Who this might be right for
Age-Related MaculopathyAge-Related MaculopathiesEye Diseases+2 more
Pfizer 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04239625
What this trial is testing

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Who this might be right for
Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more
Alkeus Pharmaceuticals, Inc. 200
Large-scale testing (Phase 3)Ended earlyNCT04603937
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Kodiak Sciences Inc 459
Not applicableEnded earlyNCT04270604
What this trial is testing

Biological Sample Collection for Research and Biobanking

Who this might be right for
Parkinson DiseaseDiabetes Mellitus, Type 1Macular Degeneration+4 more
New York Stem Cell Foundation Research Institute 1,279
Testing effectiveness (Phase 2)Ended earlyNCT04684394
What this trial is testing

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationRetinal DiseaseRetinal Degeneration+1 more
Gemini Therapeutics, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00467935
What this trial is testing

Scotoma Reduction in AMD Patients Treated With Ranibizumab

Who this might be right for
Macular Degeneration
Retina Research Foundation 20
Not applicableLooking for participantsNCT06491615
What this trial is testing

National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

Who this might be right for
Inherited Ophthalmic DiseasesHypopigmentation DisorderCorneal Dystrophy+4 more
National Eye Institute (NEI) 1,000
Not applicableEnded earlyNCT03894020
What this trial is testing

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Who this might be right for
Dry Age-related Macular DegenerationMacular DegenerationRetinal Disease+3 more
Gyroscope Therapeutics Limited 83
Large-scale testing (Phase 3)Ended earlyNCT04757636
What this trial is testing

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 998
Next Page